Media Coverage

18.04.22 Why some people still haven’t gotten Covid – POLITICO
05.04.22 Some people seem unable to catch COVID, scientists are trying to figure out why – Chicago Sun Times
04.04.22 Why do some people seem unable to catch COVID? Scientists are looking for answers. – USA Today
04.04.22 Daily COVID Tracker: Brazil eases restrictions for international travellers – The Cable
02.04.22 Doctor Explains Four Reasons Why Some People Don’t Get Covid – LAD Bible
01.04.22 Deliberate infection trial finds COVID symptoms don’t indicate viral shedding – Reuters
31.03.22 Open Orphan says Covid infection study may accelerate new vaccines – The Irish Times
25.03.22 Open Orphan subsidiary signs €6m contract for respiratory study – The Irish Times
24.02.22 Open Orphan appoints Mo Khan as its new chief executive – ShareCast
24.02.22 IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive – Morning Star
24.02.22 Open Orphan appoints Yamin Khan as new chief executive – The Irish Times
24.02.22 Open Orphan names Khan as new CEO – RTE
24.02.22 Cathal Friel & Mo Khan, the newly appointed CEO of Open Orphan, discuss the new board structure – Vox Markets
24.02.22 Open Orphan appoints non-executive board member as CEO – Proactive Investor
22.02.22 Potential RSV vaccine achieves regulatory step in US – The Irish Times
22.02.22 Open Orphan hails FDA award for RSV vaccine candidate – Proactive Investors
17.02.22 IN BRIEF: Positive results from Open Orphan human challenge study – Morning Star
03.02.22 Covid-19 news: US army discharges unvaccinated soldiers – NewScientist
02.02.22 Scientists deliberately gave people COVID — here’s what they learnt – Nature
02.02.22 Covid sufferers become infectious quicker than first thought, study shows – Financial Times
02.02.22 World-first COVID-19 human challenge trial – Magnet
02.02.22 ‘Human challenge’ Covid trial gives new insight into virus – The Irish Times
02.02.22 Trial deliberately infecting young adults with Covid found to be safe – RTE
02.02.22 British COVID trial deliberately infecting young adults found to be safe – Reuters
02.02.22 Covid symptoms appear much more quickly than previously thought – study – Yahoo! News
02.02.22 Covid infection takes hold in just 42 hours, pioneering London study shows – Evening Standard
02.02.22 U.K. Covid Study on Healthy People Was Safe, Researchers Say – Bloomberg
02.02.22 British Covid trial deliberately infecting young adults found to be safe – CNBC
02.02.22 World-first COVID-19 human challenge trial found to be safe for young adults – The New Daily
02.02.22 SARS-CoV-2 Human Challenge Study Provides Infection Insights – Technology Networks
02.02.22 British trial deliberately infecting young adults with COVID found to be safe – Market Screener
02.02.22 Open Orphan says Covid challenge study provides ‘invaluable insights’ – Proactive Investors
02.02.22 World’s first COVID human challenge trial found to be safe in young adults – Mail Online
18.01.22 Omicron and Long COVID: What We Know So Far – healthline
13.12.21 Open Orphan on US$13.4m contract for influenza human challenge study, their third flu deal this year – Proactive Investors
10.12.21 Open Orphan subsidiary wins $13.4m contract with US biotech company – The Irish Times
02.12.21 Omicron to test effectiveness of vaccines – China Daily
18.11.21 Open Orphan subsidiary locks in £5.1m contract with biopharma firm – ShareCast
17.11.21 Stock Watch – Open Orphan – This is
17.11.21 Open Orphan’s hVIVO wins £5.1m RSV human challenge study deal – RTE
17.11.21 Open Orphan Subsidiary Gets GBP5.1 Mln Contract – MarketWatch
16.11.21 Open Orphan subsidiary secures contract renewal with ‘major’ pharmaceutical client – ShareCast
18.10.21 Inside the lab company infecting humans with Covid – The Telegraph
18.10.21 Inside the quarantine lab where Irish company infects humans with Covid –
14.10.21 New and notable appointments at BDO, Open Orphan plc, Grant Thornton Ireland, and Bricknode – Business & Finance
14.10.21 Britain Infected Volunteers With Covid. Why Won’t the U.S.? – The New York Times
13.10.21 When Human Challenge Studies are a Better Option – Healthcare Business Today
11.09.21 Why scientists are deliberately infecting volunteers with covid-19 – The Economist
04.09.21 Researchers Infect Volunteers With Coronavirus, Hoping to Conquer Covid-19 – The Wall Street Journal
27.08.21 Researchers Ready Lab-Grown Covid-19 Delta Variant for Human Trials – The Wall Street Journal
24.08.21 Open Orphan subsidiary secures £8.1m contract for asthma study – Silicon Republic
24.08.21 Open Orphan subsidiary signs €9.5m contract for asthma study –
24.08.21 Open Orphan to test antiviral product aimed at tackling cold virus – The Irish Times
09.08.21 Open Orphan subsidiary develops human study for malaria – The Irish Times
30.07.21 Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbocharge work – FIERCE Biotech
16.07.21 The Executive Chairman of Open Orphan plc (LON:ORPH), Cathal Friel, Just Bought 2.5% More Shares – Simply Wall St
14.07.21 Open Orphan pharmaceutical company expands Covid-19 trial – The Irish Times
14.07.21 Open Orphan spin-out Poolbeg to raise £25m in IPO – The Irish Times
28.06.21 The MedTalk Podcast – Open Orphan on Covid-19 and studying the virus – EPM Magazine
10.05.21 British CRO wins contract for Covid-19 challenge virus; Dutch agency aims to slash Zolgensma prices in half – Endpoints News
10.05.21 Open Orphan plc Announces £3m COVID-19 Challenge Virus Manufacturing Contract – businesswire
10.05.21 Open Orphan subsidiary signs £3m contract for Covid-19 study – The Irish Times
05.05.21 How Human Challenge Trials Can Accelerate Vaccine Development – Scientific American
22.04.21 WHAT ARE WE WAITING FOR? – The Verge
25.02.21 Open Orphan facing up to Covid challenge – Shares Magazine
18.02.21 World’s first trial of deliberate coronavirus infection is approved – Financial Times
18.02.21 ‘If I get seriously ill, it’s worth it’: volunteers to be infected with coronavirus in world first human trials – Independent
18.02.21 Scientists win approval to infect healthy volunteers with Covid for trial – The Times
17.02.21 UK asks for volunteers to be exposed to COVID-19 for research – ABC News
17.02.21 Open Orphan gets final go-ahead for Covid-19 human trial – The Irish Times
17.02.21 UK will soon expose volunteers to Covid in world’s first ‘human challenge’ study – CNBC
17.02.21 COVID-19: Volunteers to be exposed to virus in world-first study in UK – Sky News
17.02.21 World’s first coronavirus Human Challenge study receives ethics approval in the UK – GOV.UK
17.02.21 Covid-19: World’s first human challenge trials to start in UK – BBC News
17.02.21 In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19 – CTV News
17.02.21 In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19 – Reuters
17.02.21 Up to 90 volunteers in UK to take part in pioneering Covid infection trial – The Guardian
17.02.21 Covid-19 roundup: EC strikes deals with Pfizer, Moderna for another 350 million vaccine doses; UK ethics body OKs challenge trial – Endpoints News
16.02.21 N.Y. Reopening Amusement Parks; EU Vaccine Deal: Virus Update – Bloomberg
04.02.21 Open Orphan starts trials on nasal spray COVID-19 vaccines – YAHOO! Finance
03.02.21 Open Orphan opens new quarantine clinic in London
11.01.21 Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials – Biopharma Reporter
11.01.21 Open Orphan’s first volunteer receives intranasal Covid-19 vaccine in clinical trial –
11.01.21 Nasal Covid vaccine can be potential game-changer – The Shillong Times
11.01.21 Inhaling away the virus: Is the next generation of COVID vaccines on its way? – ABC News
23.12.20 Shares in Ireland’s Open Orphan vaccine human testing firm climb 352% in 2020 – Irish Examiner
23.12.20 Open Orphan company successfully completes nasal spray study – The Irish Times
15.12.20 Ray of sunshine at last for suffering airlines – The Times
14.12.20 Covid-19 nasal vaccine trial given the green light – ‘no injections, no nasty reactions’ – Express UK
14.12.20 Open Orphan gets green light for Covid-19 nasal vaccine trial – The Irish Times
14.12.20 Covid-19 nasal vaccine trial given the green light – ‘no injections, no nasty reactions’ – USA Today Post
14.12.20 Dublin pharmaceutical firm gets approval for Covid-19 nasal vaccine trial – Irish Examiner
14.12.20 Venn Life Sciences wins another Covid-19 drug study – The Science Advisory Board
07.12.20 Venn Life Sciences wins another Covid-19 drug study – The Irish Times
07.12.20 Open Orphan unit Venn Life Sciences lands two new clients – Proactive Investors
07.12.20 Open Orphan two new contracts awarded to Venn Life Sciences – Director’s Talk Interviews
22.10.20 World’s first Covid human challenge trials to start in London – Financial Times
22.10.20 Coronavirus: Researchers will infect volunteers to find lowest dose that causes Covid – Times
22.10.20 UK plan to be first to run human challenge Covid trials – BBC News
22.10.20 Coronavirus: UK becomes first country to back studies that would deliberately infect volunteers with COVID-19 – Sky News
22.10.20 Coronavirus vaccine: UK volunteers to be deliberately infected people with virus – Independent
22.10.20 Open Orphan subsidiary hVivo signs deal for Covid-19 challenge study – Irish Times
22.10.20 RTE
22.10.20 Open Orphan subsidiary wins contract with the British Government – Irish Independent
22.10.20 UK government signs contract for first coronavirus human challenge studies – CNN
22.10.20 Covid ‘challenge trial’ launched in U.K. will see healthy volunteers infected with virus – NBC
22.10.20 A human challenge trial will begin in January, in which volunteers are deliberately exposed to the virus – New York Times
22.10.20 Britain to infect healthy volunteers with coronavirus in vaccine challenge trials – Washington Post
22.10.20 UK backs COVID-19 vaccine trials that infect volunteers – Reuters
22.10.20 Open Orphan to develop UK Covid-19 human challenge study model – European Pharmaceutical Manufacturer
22.10.20 U.K. Paves Way for First Tests to Expose People to Coronavirus – Bloomberg
22.10.20 U.K. set to infect volunteers with coronavirus in world’s first COVID-19 challenge study – Fierce Biotech
22.10.20 UK launches world’s first human challenge trial for COVID-19 with Irish company hVivo – YAHOO Finance
22.10.20 UK launching controversial vaccine trials where volunteers will be infected with the coronavirus – ABC News
22.10.20 Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials – Nature
22.10.20 UK taps Open Orphan to explore vaccine trials that infect volunteers with coronavirus – CNBC
22.10.20 UK backs COVID-19 vaccine trials that infect volunteers – ABC
22.10.20 UK biotech rockets up on Covid-19 ‘breakthrough’ for inhaled interferon beta — can its small study live up to the boast? – Endpoint News
22.10.20 UK to spend £30m on trials infecting young people to hasten Covid vaccine – The Guardian
22.10.20 UK plans to infect healthy volunteers in COVID-19 research trials – Aljazeera
22.10.20 U.K. to infect healthy volunteers in Covid-19 vaccine research trial – Stat News
22.10.20 UK government signs contract for COVID-19 challenge trial – PharmaPhorum
22.10.20 UK trial plans to infect volunteers with the coronavirus in January – New Scientist
29.09.20 New £4.3m Challenge Study Contract Win with Global Top 10 Vaccine Company –
29.09.20 Open Orphan wins new contract –
28.09.20 Open Orphan new £4.3m challenge study contract win with global top 10 vaccine company – Directors Talk Interviews
28.09.20 Dublin-listed Open Orphan wins €4.7m challenge study contract –
22.09.20 Open Orphan wins contract to support European pharma giant – The Irish Times
22.09.20 Open Orphan subsidiary wins contract with ‘major’ European pharma company –
17.08.20 Biotech Startup Codagenix Plans Human Trials for COVID-19 Vaccine – BioSpace
10.08.20 Open Orphan signs €4.4m contract with global company – RTE
10.08.20 Open Orphan wins €4m contract to conduct trial for new RSV treatment – The Irish Times
10.08.20 Open Orphan signs contract worth £4m –
04.08.20 Open Orphan signs new pharma trial contract with Carna – ShareCast
04.08.20 Open Orphan deal to generate ‘significant revenue’ for Venn Life Sciences – The Irish Times
04.08.20 Open Orphan inks new contract with Carna Bioscience – Vox Markets
28.07.20 Open Orphan agrees contract for Covid-19 vaccine trial – RTE
28.07.20 Open Orphan signs deal to carry out Covid-19 vaccine trial – The Irish Times
28.07.20 Open Orphan wins contact for Covid-19 vaccine trial –
02.07.20 Connect: Is antibody testing really a passport to Covid freedom? – Metro
24.06.20 Open Orphan developing world first challenge study model for Covid-19 vaccines – RTE
24.06.20 Open Orphan primed for profitability after transformational year – Proactive Investors
24.06.20 Open Orphan develops first challenge study model to test Covid-19 vaccines – The Irish Times
15.06.20 Open Orphan sees positive trial on mosquito-borne disesases – The Irish Times
15.06.20 Open Orphan study results published in The Lancet
12.06.20 How a vaccine made of mosquito spit could help stop the next epidemic – The Times of India
08.06.20 hVIVO offers coronavirus antibody testing to UK employers –
07.06.20 Coronavirus vaccine: wanted — human guinea pigs to be infected with Covid-19 – The Times
06.06.20 UP THE ANTI I took the antibody test that could help get millions back to work – by revealing they’ve had Covid WITHOUT realising – The Sun
02.06.20 Wanted: People willing to get sick to find Coronavirus vaccine – The Wall Street Journal
26.06.20 Inside stories fo Coronavirus battlers Aerogen, Hibergene, Open Orphan and Nearform – The Times
14.05.20 Irish companies come out in force to help during COVID-19 pandemic – The Irish Times
11.05.20 Open Orphan enters COVID-19 antibody testing partnership –
11.05.20 One idea for speeding a Coronavirus vaccine: Deliberately infecting people – The Wall Street Journal
11.05.20 Open Orphan. Quotient form COVID-19 antibody testing pact – Shares Magazine
11.05.20 Open Orphan’s rapid growth continues with COVID-19 antibody test deal (ORPH) – Value The Markets
11.05.20 Open Orphan inks contract with Quotient on COVID-19 antibody testing – ShareCast
23.04.20 Open Orphan subsidiary starts testing drug for treating COVID-19 –
23.04.20 Dublin-listed Open Orphan to test COVID-19 drug through London subsidiary – The Irish Times
22.04.20 Scientists are calling for vaccine experiments that would deliberately infect people with the novel Coronavirus – BuzzFeed News
23.03.20 Race to stop the world getting sick: as Coronavirus ravages the globe, experts work round the clock developing vaccines and trialling drugs in desperate attempt to contain it – Mail Online
11.03.20 Coronavirus: Inside UK clinic where people get paid up to £4,000 to be infected in race to find vaccine – Mirror
10.03.20 Open Orphan joint venture’s flu trial showcased in peer reviewed journal – Proactive Investors
10.03.20 Open Orphan positive results from Phase llb field study of FLU-v vaccine – Directors Talk Interviews
09.03.20 Open Orphan restarts earlier Coronavirus vaccine efforts – Scrip: Informa Pharma Intelligence
09.03.20 Coronavirus: Open Orhan to restart vaccine efforts – The Irish Times
09.03.20 People paid £3,500 to be infected with Coronavirus to find cure – Metro
09.03.20 Volunteers to be infected with Coronavirus for £3,500 in bid to find vaccine – The Sun
09.03.20 Open Orphan PLC joins coronavirus battle – Proactive Investors
09.03.20 Irish company to begin Coronavirus vaccine trials – Breaking
09.03.20 Get paid to have Coronavirus: Scientists in London will pay volunteers £3,500 to be infected in experiments to develop vaccine for deadly virus – Mail Online
09.03.20 Open Orphan launches world’s first human Coronavirus challenge study – EPM Magazine
09.03.20 Open Orhan starts on Coronavirus challenge study model – Morning Star
09.03.20 People being offered £3,500 to be infected with Coronavirus in bid to find cure – Birmingham Live
09.03.20 Open Orphan’s Cathal Friel on firm’s “milestone” human Coronavirus challenge study (ORPH) – Value The Markets
08.03.20 Coronavirus volunteers to be paid £3,500 and infected with form of bug – Daily Star
08.03.20 Coronavirus vaccine race: volunteers to be infected in the UK – The Times
08.03.20 Volunteers to be infected with Coronavirus for £3,500, in bid to find vaccine – Mirror
06.03.20 New hVIVO contract signed with a European Biotech Company – PharmiWeb
27.09.19 hVIVO to present at the 2019 European Respiratory Society (ERS) International Congress Madrid
19.09.19 Unaudited Interim Results for the Six Months Ended 30 June 2019
23.08.19 Notice of interim results 2019
06.08.19 hVIVO Successfully Completes RSV Challenge Study in Older Adults
31.07.19 AGS-v PLUS Phase 1
31.07.19 FD Change July 2019
17.06.19 hVIVO RSV Challenge Model Delivers Positive Results for Novel Therapy
26.04.19 2018 Annual Report
11.04.19 Preliminary Results for the Year Ended 31 December 2018
29.03.19 hVIVO & Imutex Limited to Present at IVW 2019
08.03.19 Notice of Preliminary Results 2018
10.01.19 Positive Data for Phase IIb FLU-v Challenge Study
31.10.18 AGS-v Partial Preliminary Results
08.10.18 Two New Contracts for RSV Human Challenge Studies
08.10.18 Directorate Change
20.09.18 Interim Results
18.06.18 hVIVO Reports Positive Results from the Phase IIb Field Study of FLU-v (FLU-v 003)
23.05.18 Result of AGM
27.04.18 Posting of 2017 Annual Report and Financial Statements
19.04.18 Audited 2017 Preliminary Results
19.04.18 Chief Executive Officer Steps Down
10.04.18 Statement regarding share price
06.04.18 Notice of Preliminary Results
26.03.18 Initial results from Imutex’s Phase IIb study of FLU-v
30.10.17 Directorate Change
21.09.17 Half-year Financial Report
20.06.17 Board Change
24.05.17 Results of AGM
28.04.17 Posting of 2016 Annual Report and Financial Statements
20.04.17 Audited 2016 Preliminary Results
13.04.17 Trading Update
21.02.17 hVIVO notes the initiation of a Phase I clinical trial with AGS-v
09.02.17 Data from PrEP Biopharm’s two Phase IIa clinical studies
30.12.16 Change of auditor
22.09.16 Half-year Financial Report
21.09.16 Trading update
02.09.16 hVIVO Landmark Asthma Study Underway
14.06.16 Favourable results for PrEP Biopharm’s Flu Study
24.05.16 David Norwood Lock-in Deed
23.05.16 Result of AGM
28.04.16 Posting of 2015 Annual Report and Financial Statements
25.04.16 Initial results for PrEP Biopharm’s PrEP-001 Phase IIa Flu Study
22.04.16 Joint Venture Investment with the SEEK Group
20.04.16 Board Changes
20.04.16 Audited 2015 Preliminary Results
15.12.15 Result of General Meeting
26.11.15 Conditional Placing to raise £20.5 million
02.11.15 hVIVO invests in PrEP Biopharm Limited
02.11.15 Trading Update
24.09.15 Half Yearly Report
26.05.15 Result of AGM
24.04.15 Posting of 2014 Annual Report and Financial Statements
16.04.15 Audited 2014 Preliminary Results
16.04.15 Confirmation of change of name to hVIVO plc
13.04.15 Change of Name to hVIVO
16.02.15 Trading Update
25.11.14 Trading Update
07.10.14 Board change
25.09.14 Half Yearly Report
01.09.14 Result of General Meeting
21.08.14 hVIVO HCM of GS-5086 in RSV for Gilead Sciences
14.08.14 Conditional Placing to raise £33.6 million
28.07.14 hVIVO HCM study of AL-8176 in RSV for Alios BioPharma
14.07.14 Board change
26.06.14 Board change
12.06.14 Board changes
04.06.14 Start of hVIVO challenge study in asthma
02.06.14 Investor Event
21.05.14 Result of AGM
17.04.14 Posting of 2013 Annual Report and Accounts
09.04.14 Board Changes
09.04.14 Audited 2013 Preliminary Results
19.03.14 New state of the art biomedical facility in UK
04.03.14 Acquisition
16.12.13 Trading Update
26.09.13 Half Yearly Report
28.08.13 Contract Win
23.08.13 Contract Win
02.07.13 Result of General Meeting
01.07.13 Contract Win
14.06.13 Conditional Placing to raise £25.5 million
19.04.13 Posting of 2012 Annual Report and Accounts
10.04.13 Audited 2012 Preliminary Results
07.01.13 Contract Win
12.12.12 Trading Update
22.10.12 Contract Win
24.09.12 Half Yearly Report
10.05.12 Contract Win
03.05.12 First day of Dealings and Admission to AIM